We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Episurf Medical has announced FDA 510(k) clearance of ...

Episurf Medical AB (publ) today announced that its board of directors has resolved to initiate a strategic review of the Company's medtech operations, with the aim of evaluating alternatives to unlock ...

Last week saw the public release of a collaborative project from Touch Surgery and Episurf Medical aimed at providing a surgical simulation training tool for Episurf Medical’s Episealer line of ...

Stockholm, August 15, 2011 — NASDAQ OMX (NASDAQ:NDAQ) announces that the trading in Episurf Medical AB (EPIS B) shares commenced today on First North at NASDAQ OMX Stockholm. Episurf Medical belongs ...

Episurf Medical AB (publ) (NASDAQ: EPIS B) ("Episurf" or the "Company") has today, 26 January 2026, entered into an agreement regarding the acquisition of a property portfolio consisting of ...

Stockholm, June 11, 2014 — NASDAQ OMX (NASDAQ:NDAQ) announced that Episurf Medical AB (short name: EPIS B), a Small Cap company within the Health Care sector, has started trading of its shares on the ...

Episurf Medical AB engages in patient-specific technology for the treatment of painful joint injuries. It provides solutions composing of individual implant, surgical drill guides, and patient ...

The dollar stood just shy of recent highs on Tuesday as traders counted down to a U.S.-imposed deadline for Iran to open the Persian Gulf to shipping or face attacks on its infrastructure. Reuters, ...

The table below includes insider transactions amounts, trade dates and executives completing transactions. Episurf Medical insider trades include the CEO, CFO, board of directors and is updated today.

Episurf Medical AB Series B Annual stock financials by MarketWatch. View the latest EPSFF financial statements, income statements and financial ratios.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...